Grifols Sa  (GRFS)
Other Ticker:  
Price: $9.2900 $0.16 1.752%
Day's High: $9.3199 Week Perf: 8.78 %
Day's Low: $ 9.09 30 Day Perf: 21.76 %
Volume (M): 917 52 Wk High: $ 12.15
Volume (M$): $ 8,523 52 Wk Avg: $8.87
Open: $9.20 52 Wk Low: $6.35

 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 304
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Grifols Sa
Grifols SA is a Spanish multinational pharmaceutical and chemical company. It specializes in the production of plasma-derived medicines, diagnostics systems, and medical devices. Grifols' main products include plasma-derived proteins for therapeutic use, such as immunoglobulins, albumin, clotting factors, and alpha1-antitrypsin. The company also provides blood collection and diagnostic equipment, as well as laboratory testing services. Grifols operates globally and has a strong presence in Europe, North America, and Asia. It is committed to improving the health and well-being of patients worldwide through its innovative healthcare solutions.

   Company Address: Avinguda de la Generalitat, 152-158 Barcelona 8174 CA
   Company Phone Number: 93 571 02 21   Stock Exchange / Ticker: NASDAQ GRFS
   GRFS is expected to report next financial results on April 17, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Clinical Study

Grifols Announces Positive Topline Results from Phase 3 Fibrinogen Clinical Trial

Published Wed, Feb 14 2024 8:17 AM UTC

Grifols, a renowned producer of plasma-derived medicines, has recently revealed positive topline results from its phase 3 clinical trial of BT524, a fibrinogen concentrate (FC) for the treatment of acquired fibrinogen deficiency (AFD). This development showcases the potential of BT524 to address an underserved growth market.Fibrinogen Deficiency and its Impact:Acquired Fibri...



About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com